INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 240 filers reported holding INSMED INC in Q3 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $167,888 | +164.7% | 6,650 | +121.2% | 0.00% | – |
| Q2 2023 | $63,437 | +28.9% | 3,007 | +4.1% | 0.00% | – |
| Q1 2023 | $49,222 | -7.1% | 2,889 | +9.7% | 0.00% | – |
| Q4 2022 | $52,993 | -8.6% | 2,634 | -3.5% | 0.00% | – |
| Q3 2022 | $58,000 | +16.0% | 2,730 | +9.2% | 0.00% | – |
| Q2 2022 | $50,000 | -5.7% | 2,500 | +11.8% | 0.00% | – |
| Q1 2022 | $53,000 | -8.6% | 2,236 | +4.5% | 0.00% | – |
| Q4 2021 | $58,000 | +52.6% | 2,140 | +56.4% | 0.00% | – |
| Q3 2021 | $38,000 | +26.7% | 1,368 | +25.2% | 0.00% | – |
| Q2 2021 | $30,000 | -61.0% | 1,093 | -51.0% | 0.00% | – |
| Q1 2021 | $77,000 | +18.5% | 2,232 | +12.7% | 0.00% | – |
| Q4 2020 | $65,000 | +22.6% | 1,981 | +16.5% | 0.00% | – |
| Q3 2020 | $53,000 | +39.5% | 1,701 | +17.9% | 0.00% | – |
| Q2 2020 | $38,000 | +81.0% | 1,443 | +14.6% | 0.00% | – |
| Q1 2020 | $21,000 | – | 1,259 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 5,889,491 | $100,415,822 | 8.32% |
| Deep Track Capital, LP | 6,500,000 | $110,825,000 | 4.55% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,932,138 | $49,992,953 | 2.11% |
| Endurant Capital Management LP | 230,006 | $3,921,602 | 2.01% |
| Ikarian Capital, LLC | 485,000 | $8,269,250 | 1.88% |
| MPM BioImpact LLC | 399,192 | $6,806,224 | 1.77% |
| SECTORAL ASSET MANAGEMENT INC | 516,092 | $8,799,369 | 1.69% |
| Novo Holdings A/S | 1,339,304 | $22,835,133 | 1.51% |
| First Light Asset Management, LLC | 750,883 | $12,802,555 | 1.15% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 143,794 | $2,451,688 | 1.01% |